Stryker Corporation
Stryker
SYK · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $25.1B
- Assets
- $47.8B
- SEC filing
- DEF 14A
- Filed
- March 23, 2026
Executive Compensation
Compensation reported for Stryker’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Kevin A. Lobo
Chair, Chief Executive Officer And President
$21.4M
Reported total
- Salary
- $1,491,667
- Stock awards
- $9,764,136
- Incentives
- $2,250,000
- Option awards
- $6,920,781
- Other
- $974,911
Spencer S. Stiles
Group President, Orthopaedics
$6.3M
Reported total
- Salary
- $792,500
- Stock awards
- $2,685,078
- Incentives
- $760,000
- Option awards
- $1,903,300
- Other
- $188,081
J. Andrew Pierce
Group President
$6.3M
Reported total
- Salary
- $792,500
- Stock awards
- $2,685,078
- Incentives
- $754,148
- Option awards
- $1,903,300
- Other
- $188,081
Preston W. Wells
Vice President, Chief
$4.4M
Reported total
- Salary
- $653,431
- Stock awards
- $1,841,377
- Incentives
- $514,558
- Option awards
- $1,297,717
- Other
- $103,339
Viju S. Menon
Group President, Global Quality And Operations
$4.2M
Reported total
- Salary
- $675,000
- Stock awards
- $1,647,444
- Incentives
- $578,000
- Option awards
- $1,167,889
- Other
- $167,476
Glenn S. Boehnlein
Advisor To The Chief Executive President, Chief Financial Officer Advisor To The Chief Executive Officer And Former Vice President
$1.9M
Reported total
- Salary
- $800,000
- Stock awards
- $0
- Incentives
- $800,000
- Option awards
- $0
- Other
- $293,046
Kevin A. Lobo
Chair, Chief Executive Officer And President
$21.4M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed March 23, 2026.
- Salary
- $1.5M
- Stock Awards
- $9.8M
- Option Awards
- $6.9M
- Incentives
- $2.3M
- Other
- $975K
Historical Compensation
Kevin A. Lobo total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,491,667 | $9,764,136 | $21,401,495 |
| 2024 | $1,441,667 | $8,699,604 | $21,979,369 |
| 2023 | $1,391,667 | $6,652,884 | $20,767,847 |
Named Executive Officers
Kevin A. Lobo
Chair, Chief Executive Officer And President
Stryker · SYK
$21.4M
FY 2025 · DEF 14A
Preston W. Wells
Vice President, Chief
Stryker · SYK
$4.4M
FY 2025 · DEF 14A
Spencer S. Stiles
Group President, Orthopaedics
Stryker · SYK
$6.3M
FY 2025 · DEF 14A
J. Andrew Pierce
Group President
Stryker · SYK
$6.3M
FY 2025 · DEF 14A
Viju S. Menon
Group President, Global Quality And Operations
Stryker · SYK
$4.2M
FY 2025 · DEF 14A
Glenn S. Boehnlein
Advisor To The Chief Executive President, Chief Financial Officer Advisor To The Chief Executive Officer And Former Vice President
Stryker · SYK
$1.9M
FY 2025 · DEF 14A
Source information
- Company
- Stryker Corporation
- Ticker
- SYK · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- March 23, 2026
- SEC accession number
- 0000310764-26-000013
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company